ViroGates AS (OCSE:VIRO) FFO


OCSE:VIRO ViroGates AS OCSE:VIRO
46 GF Score
Price kr10.60
GF Value kr6.80
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is ViroGates AS FFO?

FFO (Funds from operations) only applies to REITs.

OCSE:VIRO
46GF Score
ViroGates AS OCSE:VIRO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ViroGates AS (OCSE:VIRO) Overvalued in 2026?

Based on GuruFocus' analysis, ViroGates AS stock appears to be overvalued. The current stock price of kr10.60 is trading 55.9% above its estimated GF Value™ of kr6.80. GuruFocus considers ViroGates AS to be Significantly Overvalued.

Key valuation signals for OCSE:VIRO:

  • FFO:
  • GF Value™: kr6.80 vs. price of kr10.60 (55.9% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the OCSE:VIRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ViroGates AS Business Description

Address Banevaenget 13, Birkerod, DNK, 3460
ViroGates AS is an international medical technology company that develops and markets blood tests to measure chronic inflammation at health clinics and hospitals. The company markets its blood test products under the suPARnostic brand. Its product portfolio comprises suPARnostic TurbiLatex, suPARnostic Quick Triage, and suPARnostic Auto Flex ELISA kit. These products are mainly used to measure the suPAR (soluble urokinase Plasminogen Activator Receptor) protein in the bloodstream.
46GF Score

Get the complete analysis for OCSE:VIRO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.60
Price
kr6.80
GF Value